QQQ ()
DIA ()
SPY ()
TLT ()
GLD ()
$ na
-- x --
-- x --
-- - --
-- - --
--
na
--
--
--
TBD
--
-- (--)
--
TBD --
How to Read 10-K & 10-Q Reports To View SEC Filing Reports, Please Register or Sign In
# Filing Date Period End Date Type Report Link
No Data found
Guide for Analyst Ratings To View Analyst Ratings, Please Register or Sign In
# Date Analyst Firm Upside/Downside Price Target Change Rating Change Current Rating

News

OPINIONS

 monogram-technologies-completes-fully-autonomous-saw-based-robotic-knee-replacement-procedure-on-live-patient

The Procedure Utilized Monogram's mBôs TKA System Performed in India with Shalby HospitalsGroundbreaking Procedure Delivers...

 zimmer-biomet-to-lead-orthopedic-robotics-with-monograms-ai-tech

Zimmer Biomet plans to acquire Monogram and integrate its robotic knee system into its ROSA platform to support growth and prod...

Core News & Articles

Zimmer Biomet Holdings, Inc. (NYSE and SIX: ZBH), a global medical technology leader, and Monogram Technologies Inc. (NASDAQ:MG...

 monogram-technologies-q1-eps-010-beats-012-estimate

Monogram Technologies (NASDAQ:MGRM) reported quarterly losses of $(0.10) per share which beat the analyst consensus estimate of...

 roth-mkm-maintains-buy-on-monogram-technologies-raises-price-target-to-54

Roth MKM analyst Jason Wittes maintains Monogram Technologies (NASDAQ:MGRM) with a Buy and raises the price target from $4 t...

Core News & Articles
Market-Moving News for March 17th
03/17/2025 11:58:21

MGRM: 15% | EXCLUSIVE: Monogram Technologies Tells Benzinga Co. Announces FDA 510(k) Clearance For The Monogram mBôs TKA System...

 monogram-technologies-q4-2024-gaap-eps-008-beats-011-estimate

Monogram Technologies (NASDAQ:MGRM) reported quarterly losses of $(0.08) per share which beat the analyst consensus estimate of...

 monogram-technologies-provides-510k-submission-update-following--fda-meeting-application-passed-initial-fda-review-received-additional-information-request-from-fda-fda-placed-hold-pending-complete-response-to-air

Management Anticipates That it has Sufficiently Addressed the FDA's Concerns to Mitigate the Need for a Clinical Data Reque...

 roth-mkm-initiates-coverage-on-monogram-technologies-with-buy-rating-announces-price-target-of-4

Roth MKM analyst Jason Wittes initiates coverage on Monogram Technologies (NASDAQ:MGRM) with a Buy rating and announces Pric...

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION